User profiles for Alexandra C. Racanelli
Alexandra RacanelliWeill Cornell Meddicine Verified email at med.cornell.edu Cited by 1102 |
[HTML][HTML] Targeting fibrosis: Mechanisms and clinical trials
…, M Wang, S Zhou, Y Lu, H Cui, AC Racanelli… - Signal transduction and …, 2022 - nature.com
Fibrosis is characterized by the excessive extracellular matrix deposition due to dysregulated
wound and connective tissue repair response. Multiple organs can develop fibrosis, …
wound and connective tissue repair response. Multiple organs can develop fibrosis, …
Autophagy and inflammation in chronic respiratory disease
AC Racanelli, SA Kikkers, AMK Choi, SM Cloonan - Autophagy, 2018 - Taylor & Francis
Persistent inflammation within the respiratory tract underlies the pathogenesis of numerous
chronic pulmonary diseases including chronic obstructive pulmonary disease, asthma and …
chronic pulmonary diseases including chronic obstructive pulmonary disease, asthma and …
Therapeutics by cytotoxic metabolite accumulation: pemetrexed causes ZMP accumulation, AMPK activation, and mammalian target of rapamycin inhibition
AC Racanelli, SB Rothbart, CL Heyer, RG Moran - Cancer research, 2009 - AACR
Pemetrexed represents the first antifolate cancer drug to be approved by the Food and Drug
Administration in 20 years; it is currently in widespread use for first line therapy of …
Administration in 20 years; it is currently in widespread use for first line therapy of …
[HTML][HTML] Reversal of emphysema by restoration of pulmonary endothelial cells
S Hisata, AC Racanelli, P Kermani… - Journal of Experimental …, 2021 - rupress.org
Disclosures: DJ Nolan reported personal fees from Angiocrine Bioscience outside the
submitted work; in addition, DJ Nolan had a patent number 8,465,732 issued (Angiocrine …
submitted work; in addition, DJ Nolan had a patent number 8,465,732 issued (Angiocrine …
Pemetrexed indirectly activates the metabolic kinase AMPK in human carcinomas
SB Rothbart, AC Racanelli, RG Moran - Cancer research, 2010 - AACR
The chemotherapeutic drug pemetrexed, an inhibitor of thymidylate synthase, has an important
secondary target in human leukemic cells, aminoimidazolecarboxamide ribonucleotide …
secondary target in human leukemic cells, aminoimidazolecarboxamide ribonucleotide …
[HTML][HTML] Angiopoietin 2 is associated with vascular necroptosis induction in coronavirus disease 2019 acute respiratory distress syndrome
Vascular injury is a well-established, disease-modifying factor in acute respiratory distress
syndrome (ARDS) pathogenesis. Recently, coronavirus disease 2019 (COVID-19)–induced …
syndrome (ARDS) pathogenesis. Recently, coronavirus disease 2019 (COVID-19)–induced …
The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients
MJ Satlin, R Soave, AC Racanelli, TB Shore… - Leukemia & …, 2014 - Taylor & Francis
As antimicrobial resistance increases, understanding the current epidemiology of bloodstream
infections (BSIs) in hematopoietic stem cell transplant (HSCT) recipients is essential to …
infections (BSIs) in hematopoietic stem cell transplant (HSCT) recipients is essential to …
[HTML][HTML] Lung lymphatic thrombosis and dysfunction caused by cigarette smoke exposure precedes emphysema in mice
…, K Maisel, S Zamora, S Quintero, AC Racanelli… - Scientific Reports, 2022 - nature.com
The lymphatic vasculature is critical for lung function, but defects in lymphatic function in the
pathogenesis of lung disease is understudied. In mice, lymphatic dysfunction alone is …
pathogenesis of lung disease is understudied. In mice, lymphatic dysfunction alone is …
Autophagy in chronic lung disease
AC Racanelli, AMK Choi, ME Choi - Progress in molecular biology and …, 2020 - Elsevier
The development of chronic lung disease occurs as a consequence of multiple cellular events
that involve an initial insult which often leads to the development of chronic inflammation, …
that involve an initial insult which often leads to the development of chronic inflammation, …
[PDF][PDF] Integrative metabolomic and proteomic signatures define clinical outcomes in severe COVID-19
M Buyukozkan, S Alvarez-Mulett, AC Racanelli… - Iscience, 2022 - cell.com
The coronavirus disease-19 (COVID-19) pandemic has ravaged global healthcare with
previously unseen levels of morbidity and mortality. In this study, we performed large-scale …
previously unseen levels of morbidity and mortality. In this study, we performed large-scale …